Status:

COMPLETED

To Evaluate the Safety, Tolerability and Efficacy in Male and Female with AGA Treated with HMI-115 Over a 24-week Treatment Period

Lead Sponsor:

Hope Medicine (Nanjing) Co., Ltd

Conditions:

Androgenetic Alopecia

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

An Open Label Study, to Evaluate Safety, Tolerability, and Efficacy Study in Male and Female with Androgenetic Alopecia Treated with HMI-115 over a 24-Week Treatment Period.

Eligibility Criteria

Inclusion

  • Must have given written informed consent before any study-related activities are carried out and must be able to understand the full nature and purpose of the trial, including possible risks and adverse effects.
  • Male and Female subjects, between 18 and 65 years of , inclusive, at the time of signing informed consent.
  • Clinical diagnosis of androgenetic alopecia. Male subjects who meet Norwood-Hamilton scales 3v, 4 and 5. Female subjects who meet Sinclair scales 2-4.

Exclusion

  • Subject with clinical diagnosis of non-AGA
  • Subject with clinically relevant abnormal skin or scalp findings which could interfere study assessment
  • Subject has used therapies associated with hair growth or may affect PRL levels, within defined time window before Screening
  • Subject with history of anterior pituitary, posterior pituitary, or hypothalamic dysfunction
  • Subject has clinically significantly abnormal laboratory tests at Screening
  • Known hypersensitivity to any of the IMP ingredients
  • Any other conditions in the investigator's opinion that prevent the subject from participating

Key Trial Info

Start Date :

May 11 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 11 2023

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT05324293

Start Date

May 11 2022

End Date

September 11 2023

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dr Rodney Sinclair Pty Ltd, trading as Sinclair Dermatology

Melbourne E., Victoria, Australia